Class information for:
Level 2: JOURNAL OF THE RETICULOENDOTHELIAL SOCIETY//MURAMYL DIPEPTIDE//IMMUNOLOGY

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
1364 8243 31.3 53%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
210 3       IMMUNOLOGY//JOURNAL OF INTERFERON RESEARCH//NK CELLS 51916
1364 2             JOURNAL OF THE RETICULOENDOTHELIAL SOCIETY//MURAMYL DIPEPTIDE//IMMUNOLOGY 8243
6969 1                   MURAMYL DIPEPTIDE//MURAMYL PEPTIDES//PEPTIDOGLYCAN MONOMER 1422
8295 1                   ALVEOLAR MACROPHAGES//BRONCHOALVEOLAR LAVAGE//ANAT 4120 1269
9252 1                   POLY PLAT//FK 565//ACTIVATED PERITONEAL MACROPHAGES 1174
12908 1                   CAS 15687 21 1//13 HYDROXYLINOLEIC ACID//5 LIPOXYGENASE MESSENGER RNA 873
15158 1                   MIXED LEUKOCYTE RESPONSE//ALLOGENEIC T CELL ACTIVATION//AUTOLOGOUS RESETTING 728
20310 1                   TOXICOL S 216 KASHIMA YODOGAWA KU//NCPP//AMOEBOID NEUTROPHIL 466
21859 1                   BY ACTIVATED MACROPHAGES//IMPLANTED IN NUDE MICE//MACROPHAGE HUMAN 402
22973 1                   DALTONS LYMPHOMA//MAIF//MAMMARY TUMOR BEARERS 362
24095 1                   P15E//HIV 1 GP41//CKS 17 323
24453 1                   ANTI HUMAN MONOCYTE MACROPHAGE MONOCLONAL ANTIBODY//BIOPROC ANALYT//CHARLES B STOUT MASS SPE OMETRY 311
24551 1                   MILKY SPOTS//OMENTAL MILKY SPOTS//OMENTUM 308
28062 1                   BIOZZI MICE//IMUNOGENET//ANTIBODY LOCI 215
29062 1                   STEARYL TYROSINE//ADV BIOSYS INC//ESTER ANALOGS 193
35306 1                   ACUTE PHASE ALPHA 2 MACROGLOBULIN//CACHEXIA MODEL//COMPLEMENT FACTOR C3C AND C4 99
35409 1                   ANRIBELTSVILLE AGR//IMMUNO DIS ISTANCE//ONCOGENE V MYC 98

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 JOURNAL OF THE RETICULOENDOTHELIAL SOCIETY journal 101488 1% 27% 102
2 MURAMYL DIPEPTIDE authKW 92688 1% 36% 69
3 IMMUNOLOGY WoSSC 74129 45% 1% 3750
4 MILKY SPOTS authKW 67629 0% 70% 26
5 MURAMYL PEPTIDES authKW 60277 0% 53% 31
6 PEPTIDOGLYCAN MONOMER authKW 56313 0% 89% 17
7 CELLULAR IMMUNOLOGY journal 40409 4% 4% 293
8 INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY journal 37684 2% 7% 144
9 MTP PE authKW 29988 0% 90% 9
10 DALTONS LYMPHOMA authKW 29633 0% 32% 25

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Immunology 74129 45% 1% 3750
2 Respiratory System 5022 7% 0% 574
3 Cell Biology 3625 13% 0% 1031
4 Medicine, Research & Experimental 2578 8% 0% 634
5 Oncology 2558 11% 0% 913
6 Transplantation 1604 3% 0% 271
7 Hematology 1485 5% 0% 403
8 Pathology 1142 4% 0% 331
9 Pharmacology & Pharmacy 882 9% 0% 715
10 Anatomy & Morphology 334 1% 0% 87

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ANAT 4120 13930 0% 47% 8
2 IMMUNOL MOL INFECT INFLAMMAT 13220 0% 71% 5
3 MOL IMMUNOL INFECT INFLAMMAT 11566 0% 63% 5
4 TOXICOL S 216 KASHIMA YODOGAWA KU 11107 0% 100% 3
5 IMUNOGENET 7658 0% 12% 18
6 CELL IMMUNOPATHOL BIOTECHNOL 7405 0% 100% 2
7 EXPLORATORY S 216 KASHIMA YODOGAWA KU 7405 0% 100% 2
8 EXPT DIAGNOST CANC THER Y 7405 0% 100% 2
9 MACROPHAGES 7405 0% 100% 2
10 PLAST COSMET MED 6662 0% 60% 3

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 JOURNAL OF THE RETICULOENDOTHELIAL SOCIETY 101488 1% 27% 102
2 CELLULAR IMMUNOLOGY 40409 4% 4% 293
3 INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY 37684 2% 7% 144
4 JOURNAL OF LEUKOCYTE BIOLOGY 25216 3% 3% 219
5 IMMUNOBIOLOGY 15784 1% 4% 117
6 CANCER IMMUNOLOGY IMMUNOTHERAPY 12911 2% 3% 124
7 JOURNAL OF IMMUNOLOGY 12461 5% 1% 434
8 AMERICAN REVIEW OF RESPIRATORY DISEASE 11392 2% 2% 139
9 IMMUNOLOGY 9783 2% 2% 154
10 ANNALES D IMMUNOLOGIE 7706 0% 8% 27

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 MURAMYL DIPEPTIDE 92688 1% 36% 69 Search MURAMYL+DIPEPTIDE Search MURAMYL+DIPEPTIDE
2 MILKY SPOTS 67629 0% 70% 26 Search MILKY+SPOTS Search MILKY+SPOTS
3 MURAMYL PEPTIDES 60277 0% 53% 31 Search MURAMYL+PEPTIDES Search MURAMYL+PEPTIDES
4 PEPTIDOGLYCAN MONOMER 56313 0% 89% 17 Search PEPTIDOGLYCAN+MONOMER Search PEPTIDOGLYCAN+MONOMER
5 MTP PE 29988 0% 90% 9 Search MTP+PE Search MTP+PE
6 DALTONS LYMPHOMA 29633 0% 32% 25 Search DALTONS+LYMPHOMA Search DALTONS+LYMPHOMA
7 ROMURTIDE 29620 0% 100% 8 Search ROMURTIDE Search ROMURTIDE
8 OMENTAL MILKY SPOTS 25917 0% 100% 7 Search OMENTAL+MILKY+SPOTS Search OMENTAL+MILKY+SPOTS
9 OMENTUM 25651 1% 13% 53 Search OMENTUM Search OMENTUM
10 ADAMANTYLTRIPEPTIDES 22215 0% 100% 6 Search ADAMANTYLTRIPEPTIDES Search ADAMANTYLTRIPEPTIDES

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 NARDIN, A , LEFEBVRE, ML , LABROQUERE, K , FAURE, O , ABASTADO, JP , (2006) LIPOSOMAL MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE: TARGETING AND ACTIVATING MACROPHAGES FOR ADJUVANT TREATMENT OF OSTEOSARCOMA.CURRENT CANCER DRUG TARGETS. VOL. 6. ISSUE 2. P. 123-133 57 77% 52
2 ADAM, A , LEDERER, E , (1984) MURAMYL PEPTIDES - IMMUNOMODULATORS, SLEEP FACTORS, AND VITAMINS.MEDICINAL RESEARCH REVIEWS. VOL. 4. ISSUE 2. P. 111-152 99 84% 196
3 MEYERS, PA , (2009) MURAMYL TRIPEPTIDE (MIFAMURTIDE) FOR THE TREATMENT OF OSTEOSARCOMA.EXPERT REVIEW OF ANTICANCER THERAPY. VOL. 9. ISSUE 8. P. 1035-1049 42 70% 43
4 DZIERZBICKA, K , KOLODZIEJCZYK, AM , (2003) MURAMYL PEPTIDES - SYNTHESIS AND BIOLOGICAL ACTIVITY.POLISH JOURNAL OF CHEMISTRY. VOL. 77. ISSUE 4. P. 373-395 42 82% 12
5 ANDO, K , MORI, K , CORRADINI, N , REDINI, F , HEYMANN, D , (2011) MIFAMURTIDE FOR THE TREATMENT OF NONMETASTATIC OSTEOSARCOMA.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 12. ISSUE 2. P. 285-292 40 63% 21
6 MORI, K , ANDO, K , HEYMANN, D , (2008) LIPOSOMAL MURAMYL TRIPEPTIDE PHOSPHATIDYL ETHANOLAMINE: A SAFE AND EFFECTIVE AGENT AGAINST OSTEOSARCOMA PULMONARY METASTASES.EXPERT REVIEW OF ANTICANCER THERAPY. VOL. 8. ISSUE 2. P. 151-159 43 65% 9
7 HARAGUCHI, S , GOOD, RA , CIANCIOLO, GJ , ENGELMAN, RW , DAY, NK , (1997) IMMUNOSUPPRESSIVE RETROVIRAL PEPTIDES: IMMUNOPATHOLOGICAL IMPLICATIONS FOR IMMUNOSUPPRESSIVE INFLUENCES OF RETROVIRAL INFECTIONS.JOURNAL OF LEUKOCYTE BIOLOGY. VOL. 61. ISSUE 6. P. 654-666 68 54% 43
8 PABST, MJ , BERANOVA-GIORGIANNI, S , KRUEGER, JM , (1999) EFFECTS OF MURAMYL PEPTIDES ON MACROPHAGES, MONOKINES, AND SLEEP.NEUROIMMUNOMODULATION. VOL. 6. ISSUE 4. P. 261 -283 69 48% 26
9 LIU, JY , GENG, XF , LI, Y , (2016) MILKY SPOTS: OMENTAL FUNCTIONAL UNITS AND HOTBEDS FOR PERITONEAL CANCER METASTASIS.TUMOR BIOLOGY. VOL. 37. ISSUE 5. P. 5715 -5726 42 48% 0
10 SOUTO, JC , VILA, L , BRU, A , (2011) POLYMORPHONUCLEAR NEUTROPHILS AND CANCER. INTENSE AND SUSTAINED NEUTROPHILIA AS A TREATMENT AGAINST SOLID TUMORS.MEDICINAL RESEARCH REVIEWS. VOL. 31. ISSUE 3. P. 311 -363 85 24% 28

Classes with closest relation at Level 2


Rank Class id link
1 2020 CELLULAR IMMUNOLOGY//IMMUNOLOGY//EPICUTANEOUS IMMUNIZATION
2 3092 POSTOPERATIVE SEPTIC COMPLICATIONS//TREATMENT RELATED TOXICITIES//MIGRATION STIMULATION FACTOR
3 3950 KURLOFF CELL//ALPHA NAPHTHYL ACETATE ESTERASE//ANAE
4 3238 ARBIDOL//VOPROSY VIRUSOLOGII//COOPERAT MED
5 3041 PSK//OK 432//IMEXON
6 2797 FC RECEPTOR//FC GAMMA RECEPTORS//FC GAMMA RECEPTOR
7 1852 INTERLEUKIN 1//INTERLEUKIN 1 RECEPTOR ANTAGONIST//POLYMORPHISM
8 1301 CHRONIC GRANULOMATOUS DISEASE//FORMYL PEPTIDE RECEPTOR//NADPH OXIDASE
9 3536 EVOLUTIONARY IMMUNOBIOL//PERITONEAL INFLAMMATION//ZYMOSAN
10 1621 SARCOIDOSIS//NEUROSARCOIDOSIS//SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES

Go to start page